Telix Completes Acquisition of Atlab for Prostate Cancer Program
10 sept. 2018 19h30 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NANTES, France, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced completion of the acquisition of Atlab Pharma SAS...